See every side of every news story
Published loading...Updated

Anti-amyloid therapy may keep Alzheimer’s symptoms at bay in certain patients, study suggests

  • Scientists have found that a biologic drug can delay Alzheimer's symptoms in specific patients, marking a significant step in treatment options.
  • The study revealed a 50% reduction in risk of symptoms for 22 patients who took gantenerumab for an average of eight years.
  • Dr. Eric McDade stated that these results suggest a possibility of delaying Alzheimer's progression.
  • Dr. Tara Spires-Jones noted that while results are promising, they do not conclusively prove delayed onset, and some might avoid treatment due to modest benefits.
Insights by Ground AI
Does this summary seem wrong?

248 Articles

All
Left
31
Center
98
Right
18
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 67% of the sources are Center
67% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Futura broke the news in on Wednesday, March 19, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.